HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuji Nakatsuji Selected Research

Adenosine Triphosphate (ATP)

6/2021Increased cerebrospinal fluid adenosine 5'-triphosphate in patients with amyotrophic lateral sclerosis.
1/2020Cerebrospinal fluid ATP as a potential biomarker in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes (MELAS).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuji Nakatsuji Research Topics

Disease

15Multiple Sclerosis
05/2021 - 10/2004
9Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2018 - 10/2004
8Neuromyelitis Optica (Devic's Disease)
01/2023 - 03/2009
6Inflammation (Inflammations)
02/2015 - 03/2010
5Neuroinflammatory Diseases
06/2021 - 02/2010
4Parkinson Disease (Parkinson's Disease)
04/2024 - 09/2005
4Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
06/2021 - 10/2004
4Polyneuropathies (Polyneuropathy)
05/2021 - 01/2017
3Autoimmune Diseases (Autoimmune Disease)
01/2023 - 12/2011
3Demyelinating Diseases (Demyelinating Disease)
01/2017 - 11/2011
3Necrosis
01/2012 - 10/2004
2Myasthenia Gravis
01/2024 - 05/2021
2Encephalitis (Encephalitis, Rasmussen)
05/2021 - 10/2018
2Guillain-Barre Syndrome
05/2021 - 01/2018
2Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
01/2021 - 01/2017
2Relapsing-Remitting Multiple Sclerosis
03/2020 - 01/2018
1Muscle Weakness
01/2024
1Dyspnea (Shortness of Breath)
01/2024
1Hepatocellular Carcinoma (Hepatoma)
01/2024
1Liver Neoplasms (Liver Cancer)
01/2024
1Myocarditis (Carditis)
01/2024
1Myositis (Idiopathic Inflammatory Myopathies)
01/2024
1Ataxia (Dyssynergia)
08/2023
1Chorea (Rheumatic Chorea)
08/2023
1Lung Neoplasms (Lung Cancer)
08/2023
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
08/2023
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2023
1Optic Neuritis (Retrobulbar Neuritis)
12/2021
1Movement Disorders (Movement Disorder)
10/2021
1Nervous System Diseases (Neurological Disorders)
05/2021
1Autoimmune Diseases of the Nervous System
05/2021
1MELAS Syndrome (Syndrome, MELAS)
01/2020
1Infections
10/2019
1Bacterial Meningitis
10/2019
1Disease Progression
01/2019
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2019
1Respiratory Insufficiency (Respiratory Failure)
05/2018
1Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis)
05/2018
1Neuroendocrine Carcinoma
02/2018
1Polyradiculoneuropathy (Polyradiculoneuritis)
01/2018
1Arthritis (Polyarthritis)
02/2015
1Rheumatoid Arthritis
02/2015

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
01/2021 - 10/2012
3Xanthine OxidaseIBA
04/2024 - 01/2013
3anti-aquaporin 4 autoantibodyIBA
05/2021 - 03/2010
3Lactic Acid (Lactate)FDA LinkGeneric
01/2020 - 01/2011
3Immunoglobulin G (IgG)IBA
10/2018 - 03/2009
3AutoantibodiesIBA
10/2018 - 03/2009
3Semaphorins (Semaphorin)IBA
09/2015 - 06/2006
3CytokinesIBA
02/2015 - 10/2004
2Proteins (Proteins, Gene)FDA Link
08/2023 - 01/2017
2Adenosine Triphosphate (ATP)IBA
06/2021 - 01/2020
2Acetates (Acetic Acid Esters)FDA Link
01/2021 - 01/2014
2Mitochondrial DNA (mtDNA)IBA
01/2020 - 04/2018
2MethylprednisoloneFDA LinkGeneric
01/2016 - 01/2015
2Interleukin-6 (Interleukin 6)IBA
02/2015 - 03/2013
2ChemokinesIBA
02/2015 - 03/2013
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2013 - 08/2008
2Complement System Proteins (Complement)IBA
01/2012 - 03/2009
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2005 - 10/2004
1AntioxidantsIBA
04/2024
1atezolizumabIBA
01/2024
1Immune Checkpoint InhibitorsIBA
01/2024
1durvalumabIBA
08/2023
1Semaphorin-3AIBA
08/2023
1DNA (Deoxyribonucleic Acid)IBA
01/2023
1HLA-DRB1*04 antigenIBA
12/2021
1HLA-DRB1 Chains (HLA DRB1)IBA
12/2021
13-Iodobenzylguanidine (Iobenguane)IBA
10/2021
1neuromelaninIBA
10/2021
1Carboxy-LyasesIBA
10/2021
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
10/2021
1Dopa DecarboxylaseIBA
10/2021
1Monoamine Oxidase (MAO)IBA
10/2021
1Adenosine (Adenocard)FDA LinkGeneric
06/2021
1Intravenous Immunoglobulins (IVIG)FDA Link
01/2021
1Interleukin-17 (Interleukin 17)IBA
03/2020
1LuciferasesIBA
01/2020
1Methicillin (Metin)FDA Link
10/2019
1Anti-Bacterial Agents (Antibiotics)IBA
10/2019
1Epoprostenol (Prostacyclin)FDA LinkGeneric
01/2019
1Vasodilator Agents (Vasodilators)IBA
01/2019
1Glutamic Acid (Glutamate)FDA Link
01/2019
1CDw17 antigen (lactosylceramide)IBA
05/2018
1Calcium Channels (Calcium Channel)IBA
02/2018
1AntibodiesIBA
02/2018
1Fingolimod Hydrochloride (FTY720)FDA Link
01/2018
1NivolumabIBA
01/2018
1FebuxostatFDA Link
01/2017
1EpiregulinIBA
02/2015
1AmphiregulinIBA
02/2015
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
02/2015
1TenascinIBA
02/2015
1BetacellulinIBA
02/2015

Therapy/Procedure

10Therapeutics
10/2019 - 10/2004
2Transcranial Direct Current Stimulation
10/2021 - 01/2018
2Plasma Exchange
05/2021 - 01/2017
1Transcranial Magnetic Stimulation
10/2021
1Blood Component Removal (Apheresis)
05/2021
1Artificial Respiration (Mechanical Ventilation)
05/2018